lobbying_activities: 1224486

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1224486	0bca596b-8999-4965-bbd8-41bcf1f0b1c9	Q1	VENABLE LLP	39941	ENDO PHARMACEUTICALS INC	2012	first_quarter	PHA	General issues affecting the pharmaceutical industry and bioequivelence. (Generic pharmaceutical user fee act.) The Life Sciences Investment Act (S. 1410; H.R. 2632)	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2012-04-10T13:20:40.280000-04:00